Generate Biomedicines, Inc. (GENB)

NASDAQ: GENB · Real-Time Price · USD

15.03

-0.06 (-0.40%)

At close: Aug 13, 2026, 4:00 PM EDT

15.13

+0.10 (0.67%)

Pre-market: Aug 14, 2026, 5:41 AM EDT

Generate Biomedicines Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Equivalents	135.36	121.65	176.27
Short-Term Investments	322.06	99.85	217.36
Cash & Short-Term Investments	457.42	221.5	393.63
Cash Growth	16.20%	-43.73%	-
Accounts Receivable	-	-	0.31
Other Current Assets	12.84	12.87	13.56
Total Current Assets	470.25	234.37	407.49
Net Property, Plant & Equipment	82.38	89.01	101.07
Other Long-Term Assets	9.06	6.81	9.7
Total Assets	561.69	330.18	518.26
Accounts Payable	5.65	3.84	5.67
Accrued Expenses	25.2	42.16	21.77
Current Portion of Leases	13.62	15.01	16.72
Unearned Revenue	12.17	21.19	42.43
Other Current Liabilities	-	-	0.05
Total Current Liabilities	56.64	82.2	86.63
Long-Term Leases	49.01	53.52	60.26
Other Long-Term Liabilities	-	5.83	16.62
Total Long-Term Liabilities	49.01	59.35	76.87
Total Liabilities	105.65	141.55	163.5
Common Stock	0.13	0.03	0.03
Additional Paid-in Capital	1,261	60.19	38.47
Accumulated Other Comprehensive Income	-0.13	0.11	0.12
Retained Earnings	-804.99	-676.29	-473.14
Total Common Shareholders' Equity	456.05	-615.97	-434.52
Minority Interest	-	804.59	789.28
Shareholders' Equity	456.05	188.63	354.76
Total Liabilities & Equity	561.69	330.18	518.26
Total Debt	62.63	68.53	76.97
Net Cash (Debt)	394.79	152.97	316.66
Net Cash Growth	24.67%	-51.69%	-
Net Cash Per Share	6.09	4.64	9.87
Book Value	456.05	-615.97	-434.52
Book Value Per Share	7.04	-18.68	-13.54
Tangible Book Value	456.05	-615.97	-434.52
Tangible Book Value Per Share	7.04	-18.68	-13.54

SEC Filings: 10-K · 10-Q